Tesaro   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Waltham MA United States (2010)
Status: Acquired by GlaxoSmithKline (2019)

Organization Overview

First Clinical Trial
2010
NCT00749502
First Marketed Drug
2010
rolapitant (varubi)
First NDA Approval
2015
rolapitant (varubi)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Tesaro Inc., | Tesaro, Inc. | TESARO INC